Preventing Vascular Complications in Type Diabetes Muscle Metabolic Monitoring
Award amount
$183,142Program and phase
STTR · Phase IAward year
2017Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Infrared Rx, Inc.
- Proposal award date
- 2017-09-18
- Contract end date
- 2019-09-17
- UEI
- WCBQFL361VY1
- Solicitation number
- PA14-059
- Topic code
- NIDDK
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Oxygen-Guided Therapy for Optimal Rehabilitation for Peripheral Artery Disease
- Preventing Vascular Complications in Type 1 Diabetes: Muscle Metabolic Monitoring
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- ND Enabling Studies for CMT-101, a Novel Gene Therapy for Glycogen Storage Disease 1b
- Wearable Metabolic Sensor for Monitoring of Lactate and Glucose for People with Diabetes
- Novel Over-the-Scope Platform for Control of Variceal Bleeding
- Tolerogenic Nanotherapy to Delay Type I Diabetes
- An intravascular Bioartificial Pancreas (iBAP)
Research funding history
3 SBIR/STTR records share this UEI (2017–2021). Reported award amounts total $1,784,593. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services